我们对AUPH进行了更新,请前往我们...查看全文
chuminhua2019-12-03 20:45
12/2,Kodiak Sciences$Kodiak Sciences(KOD)$ 将眼科药物KSI-301的全球净销售额4.5%出售给Baker Bros. Advisors,获得2.25亿美元开发经费。KSI-301用于视网膜静脉堵塞,湿性AMD和糖尿病性黄斑水肿。交易预计将在明年1月完成,包括100万美元前期款,1.25亿美元里程金。KSI-301和重磅药物Elyea同样...查看全文
狂拉的麦克斯2019-12-03 09:47
$Kodiak Sciences(KOD)$ Kodiak Sciences (NASDAQ:KOD) launches a $250M public offering of common stock. Underwriters' over-allotment is an additional $37.5M of stock. Price, volume and terms have yet to be announced.查看全文
Replix锐璞美股2019-12-03 09:25
$Correvio药业(CORV)$ 本月CORV有两个重磅的催化剂出炉,我们更新了其研究报告,请查看:网页链接。
$Audentes(BOLD)$ $Kodiak Sciences(KOD)$
@淘沙见金 @飞冲天 @书呆老李 @Efficacious @Replix锐璞-Yang @美股医药Z博士 @药师老庙 @跑江糊查看全文
Replix锐璞美股2019-12-03 09:23
我们更新了我们的持仓,请查看:网页链接。
$Audentes(BOLD)$ $Kodiak Sciences(KOD)$
@淘沙见金 @飞冲天 @书呆老李 @Efficacious @Replix锐璞-Yang @美股医药Z博士 @药师老庙 @跑江糊查看全文
Replix锐璞美股2019-12-03 08:46
$Albireo Pharma(ALBO)$ 近期医药板块的上涨ALBO并没有享受到,作为一家2020年Q3有临床三期结果出炉的小型医药公司,值得我们分析,分析报告:网页链接。
$Audentes(BOLD)$ $Kodiak Sciences(KOD)$
@淘沙见金 @飞冲天 @书呆老李 @Efficacious @Replix锐...查看全文
NoctisLight2019-12-03 08:38
$Kodiak Sciences(KOD)$ 250m的deal, 先不谈到时候能不能公司通过这笔交易挣钱, 即便能挣钱100%利润250m 也是不足公司市值的1/10,但这个消息却把市值炒高2.3倍, 然后强取豪夺增发股票,割草. 非常道.查看全文
Replix锐璞美股2019-12-03 08:34
$Xenon制药(XENE)$ 处于催化剂空窗期的小医药股通常表现不好,XENE的催化剂要等到明年下半年,但这家公司有一些看点值得关注,请查看我们的分析:网页链接。
$Audentes(BOLD)$ $Kodiak Sciences(KOD)$
@淘沙见金 @飞冲天 @书呆老李 @Efficacious @Repli...查看全文
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080612 Size: 22 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018665 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018655 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018658 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018663 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018661 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017449 Size: 11 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016682 Size: 9 KB 网页链接
$Kodiak Sciences(KOD)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-156056 Act: 34 Size: 148 KB 网页链接
$Kodiak Sciences(KOD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060483 Act: 34 Size: 4 MB 网页链接